Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

E-ISSN： 1741-203x|25|5|707-719

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.25, Iss.5, 2013-05, pp. : 707-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design

International Psychogeriatrics, Vol. 27, Iss. 2, 2015-02 ,pp. : 181-197

Cambridge University Press

Access to resources Recommend Favorite

Developing medicines for agitation and aggression in Alzheimer's disease

International Psychogeriatrics, Vol. 27, Iss. 2, 2014-12 ,pp. : 179-179

Cambridge University Press

Access to resources Recommend Favorite

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

International Psychogeriatrics, Vol. 27, Iss. 12, 2015-12 ,pp. : 2059-2067

Cambridge University Press

Access to resources Recommend Favorite

Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies – ADDENDUM

International Psychogeriatrics, Vol. 26, Iss. 10, 2014-07 ,pp. : 1753-1753

Cambridge University Press

Access to resources Recommend Favorite

Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies

International Psychogeriatrics, Vol. 25, Iss. 5, 2013-01 ,pp. : 687-689

Cambridge University Press

Access to resources Recommend Favorite